Evidence map›Paper›PMID 28934493›Full record

ArticleNucleic acids research2017

UbaLAI is a monomeric Type IIE restriction enzyme.

Giedrius Sasnauskas, Giedre Tamulaitiene, Gintautas Tamulaitis, Jelena Calyševa, Migle Laime, Renata Rimšeliene, Arvydas Lubys, Virginijus Siksnys

Abstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. The crystal structure of theThe Journal of biological chemistry · 2018
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giedrius SasnauskasInstitute of Biotechnology, Vilnius University, Sauletekio av. 7, LT-10257 Vilnius, Lithuania.
Giedre TamulaitieneInstitute of Biotechnology, Vilnius University, Sauletekio av. 7, LT-10257 Vilnius, Lithuania.
Gintautas TamulaitisInstitute of Biotechnology, Vilnius University, Sauletekio av. 7, LT-10257 Vilnius, Lithuania.
Jelena CalyševaInstitute of Biotechnology, Vilnius University, Sauletekio av. 7, LT-10257 Vilnius, Lithuania.
Migle LaimeThermo Fisher Scientific Baltics, V. A. Graiciuno str. 8, LT-02241, Vilnius, Lithuania.
Renata RimšelieneThermo Fisher Scientific Baltics, V. A. Graiciuno str. 8, LT-02241, Vilnius, Lithuania.
Arvydas LubysThermo Fisher Scientific Baltics, V. A. Graiciuno str. 8, LT-02241, Vilnius, Lithuania.
Virginijus SiksnysInstitute of Biotechnology, Vilnius University, Sauletekio av. 7, LT-10257 Vilnius, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type II restriction endonucleases (REases) form a large and highly diverse group of enzymes. Even REases specific for a common recognition site often vary in their oligomeric structure, domain organization and DNA cleavage mechanisms. Here we report biochemical and structural characterization of the monomeric restriction endonuclease UbaLAI, specific for the pseudosymmetric DNA sequence 5'-CC/WGG-3' (where W = A/T, and '/' marks the cleavage position). We present a 1.6 Å co-crystal structure of UbaLAI N-terminal domain (UbaLAI-N) and show that it resembles the B3-family domain of EcoRII specific for the 5'-CCWGG-3' sequence. We also find that UbaLAI C-terminal domain (UbaLAI-C) is closely related to the monomeric REase MvaI, another enzyme specific for the 5'-CCWGG-3' sequence. Kinetic studies of UbaLAI revealed that it requires two recognition sites for optimal activity, and, like other type IIE enzymes, uses one copy of a recognition site to stimulate cleavage of a second copy. We propose that during the reaction UbaLAI-N acts as a handle that tethers the monomeric UbaLAI-C domain to the DNA, thereby helping UbaLAI-C to perform two sequential DNA nicking reactions on the second recognition site during a single DNA-binding event. A similar reaction mechanism may be characteristic to other monomeric two-domain REases.

Indexed as

Crystallography, X-RayDeoxyribonucleases, Type II Site-SpecificDNADNA CleavageModels, MolecularProtein DomainsSubstrate SpecificityDeoxyribonucleases, Type II Site-SpecificDNA

Identifiers

PMID28934493
PMCPMC5766183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.